Feng et al. reported that PH20 hyaluronidase and folic acid-modified exosomes can enhance doxorubicin delivery by degrading ECM and inhibit the metastasis of breast cancer caused by hyaluronidase treatment [19]. Here, SPAM1 is linked to breast carcinoma.